<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35415186</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2312-0541</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>ERJ open research</Title><ISOAbbreviation>ERJ Open Res</ISOAbbreviation></Journal><ArticleTitle>Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">00004-2022</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/23120541.00004-2022</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Long-term outcome data of coronavirus disease 2019 (COVID-19) survivors are needed to understand their recovery trajectory and additional care needs.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A prospective observational multicentre cohort study was carried out of adults hospitalised with COVID-19 from March through May 2020. Workup at 3 and 12&#x2005;months following admission consisted of clinical review, pulmonary function testing, 6-min walk distance (6MWD), muscle strength, chest computed tomography (CT) and quality of life questionnaires. We evaluated factors correlating with recovery by linear mixed effects modelling.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of 695 patients admitted, 299 and 226 returned at 3 and 12&#x2005;months, respectively (median age 59&#x2005;years, 69% male, 31% severe disease). About half and a third of the patients reported fatigue, dyspnoea and/or cognitive impairment at 3 and 12&#x2005;months, respectively. Reduced 6MWD and quadriceps strength were present in 20% and 60% at 3&#x2005;months <i>versus</i> 7% and 30% at 12&#x2005;months. A high anxiety score and body mass index correlated with poor functional recovery. At 3&#x2005;months, diffusing capacity for carbon monoxide (<i>D</i> <sub>LCO</sub>) and total lung capacity were below the lower limit of normal in 35% and 18%, decreasing to 21% and 16% at 12&#x2005;months; predictors of poor <i>D</i> <sub>LCO</sub> recovery were female sex, pre-existing lung disease, smoking and disease severity. Chest CT improved over time; 10% presented non-progressive fibrotic changes at 1&#x2005;year.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Many COVID-19 survivors, especially those with severe disease, experienced limitations at 3&#x2005;months. At 1&#x2005;year, the majority showed improvement to almost complete recovery. To identify additional care or rehabilitation needs, we recommend a timely multidisciplinary follow-up visit following COVID-19 admission.</AbstractText><CopyrightInformation>Copyright &#xa9;The authors 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lorent</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-2653-5885</Identifier><AffiliationInfo><Affiliation>Dept of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>These authors contributed equally.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vande Weygaerde</LastName><ForeName>Yannick</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-8156-9420</Identifier><AffiliationInfo><Affiliation>Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>These authors contributed equally.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Claeys</LastName><ForeName>Eveline</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Dept of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>These authors contributed equally.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guler Caamano Fajardo</LastName><ForeName>Ipek</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Leuven Biostatistics and Statistical Bioinformatics Centre (L-BioStat), KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Vos</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Dept of Radiology, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Wever</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Dept of Radiology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salhi</LastName><ForeName>Bihiyga</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gyselinck</LastName><ForeName>Iwein</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Dept of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosteels</LastName><ForeName>Cedric</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambrecht</LastName><ForeName>Bart N</ForeName><Initials>BN</Initials><AffiliationInfo><Affiliation>Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Immunoregulation, VIB-UGent Center for Inflammation Research, Flemish institute for Biotechnology, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Everaerts</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2646-4770</Identifier><AffiliationInfo><Affiliation>Dept of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verschraegen</LastName><ForeName>Sven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schepers</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Dept of Radiology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demeyer</LastName><ForeName>Heleen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Dept of Rehabilitation Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Rehabilitation Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heyns</LastName><ForeName>Arne</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7455-2762</Identifier><AffiliationInfo><Affiliation>Dept of Physical Medicine and Rehabilitation, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Depuydt</LastName><ForeName>Pieter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Immunoregulation, VIB-UGent Center for Inflammation Research, Flemish institute for Biotechnology, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oeyen</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Immunoregulation, VIB-UGent Center for Inflammation Research, Flemish institute for Biotechnology, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Bleyenbergh</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Dept of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Godinas</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Dept of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dupont</LastName><ForeName>Lieven</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Dept of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermans</LastName><ForeName>Greet</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Dept of General Internal Medicine, Medical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Derom</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Immunoregulation, VIB-UGent Center for Inflammation Research, Flemish institute for Biotechnology, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gosselink</LastName><ForeName>Rik</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0444-8606</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janssens</LastName><ForeName>Wim</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-1830-2982</Identifier><AffiliationInfo><Affiliation>Dept of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Braeckel</LastName><ForeName>Eva</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7242-0747</Identifier><AffiliationInfo><Affiliation>Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Immunoregulation, VIB-UGent Center for Inflammation Research, Flemish institute for Biotechnology, Ghent, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>ERJ Open Res</MedlineTA><NlmUniqueID>101671641</NlmUniqueID><ISSNLinking>2312-0541</ISSNLinking></MedlineJournalInfo><CoiStatement>Conflict of interest: Y. Vande Weygaerde declares consulting fees from KCE: Federaal Kenniscentrum voor de Gezondheidszorg for participating on a panel for evaluation of interventional studies concerning treatment of patients with long COVID; payment from Wetenschappelijke Vereniging voor Verzekeringsgeneeskunde for a presentation about post-COVID syndrome; and support for attending meetings and/or travel from Insmed and Chiesi, all in the 36&#x2005;months prior to manuscript submission. I. Gyselinck declares PhD grant funding from Research Foundation Flanders, in the 36&#x2005;months prior to manuscript submission. C. Bosteels declares FWO funding as a PhD student; payment or honoraria for the Basic Science GSK Award in Pulmonology 2020, AstraZeneca Award 2021 and Romain Pauwels Award 2021; and support paid to their institution for the Keystone Symposia Scholarship 2019 and the European Federation of Immunological Societies&#x2013;European Journal of Immunology Travel Grant, all in the 36&#x2005;months prior to manuscript submission. B.N. Lambrecht declares VIB grants M901 BaLa COVID-19 SARPAC trial and M902 BaLa COVID-19 COVAID trial, in the 36&#x2005;months prior to manuscript submission. S. Everaerts declares payment or honoraria from GlaxoSmithKline and Boehringer Ingelheim; payment for expert testimony from Chiesi; support for attending meetings and/or travel from GlaxoSmithKline, Chiesi and Teva; and participation on a Data Safety Monitoring Board or Advisory Board for Chiesi, all in the 36&#x2005;months prior to manuscript submission. L. Godinas declares grants and consulting fees from Merck Sharp &amp; Dohme, Biotest and Johnson &amp; Johnson, in the 36&#x2005;months prior to manuscript submission. R. Gosselink declares royalties of less than EUR 500 from Springer Verlag, in the 36&#x2005;months prior to manuscript submission. W. Janssens declares support for the present manuscript from KU Leuven/UZ Leuven COVID research funds. E. Van Braeckel declares funding for the present manuscript from the Ghent University Special Research Fund for COVID-19 Research (BOFCOV2020000801); as well as that, they hold a tenure-track position at Ghent University supported by the Special Research Fund (BOF-ZAP); and that they are Principal Investigator in a trial sponsored by Exevir Bio and sub-investigator in the ZILU-COV trial sponsored by UCB and the COV-AID and SARPAC trials sponsored by the Belgian Health Care Knowledge Centre (KCE); and, within the 36&#x2005;months prior to manuscript submission, consulting fees paid to their institution by GlaxoSmithKline and Merck Sharp &amp; Dohme, payment or honoraria to their institution from Gilead and GlaxoSmithKline and payment to their institution for participation on a data safety monitoring board or advisory board from Merck Sharp &amp; Dohme; and that they hold the unpaid roles of Chair of the Belgian Respiratory Society working group on respiratory infections, member of the Belgian COVID-19 guidelines group and that they provide unpaid COVID-19-related expert advice to Belgian government agencies. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35415186</ArticleId><ArticleId IdType="pmc">PMC8994962</ArticleId><ArticleId IdType="doi">10.1183/23120541.00004-2022</ArticleId><ArticleId IdType="pii">00004-2022</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO coronavirus disease (COVID-19) dashboard. Geneva: World Health Organization, 2020. https://www.covid19.who.int/
Date last accessed: 16 December 2021. Date last updated: 22 March 2022.</Citation></Reference><Reference><Citation>Ahmed H, Patel K, Greenwood DC, et al. . Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis. J Rehabil Med 2020; 52: jrm00063.</Citation><ArticleIdList><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty AB, Harrison EM, Green CA, et al. . Features of 20&#x2009;133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 2020; 369: m1985. doi:10.1136/bmj.m1985</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1985</ArticleId><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Tan C, Wu J, et al. . Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res 2020; 21: 163. doi:10.1186/s12931-020-01429-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01429-6</ArticleId><ArticleId IdType="pmc">PMC7323373</ArticleId><ArticleId IdType="pubmed">32600344</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AS, Wong AW, Hague CJ, et al. . A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax 2021; 76: 402&#x2013;404. doi:10.1136/thoraxjnl-2020-216308</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216308</ArticleId><ArticleId IdType="pubmed">33273023</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A, et al. . Cardiopulmonary recovery after COVID-19: an observational prospective multi-center trial. Eur Respir J 2021; 57: 2003481. doi:10.1183/13993003.03481-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03481-2020</ArticleId><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM, et al. . Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine 2021; 31: 100683. doi:10.1016/j.eclinm.2020.100683</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100683</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, et al. . 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet 2021; 398: 747&#x2013;758. doi:10.1016/S0140-6736(21)01755-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Latronico N, Peli E, Calza S, et al. . Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS. Thorax 2022; 77: 300&#x2013;303. doi:10.1136/thoraxjnl-2021-218064</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-218064</ArticleId><ArticleId IdType="pubmed">34588274</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardo MDM, Foppiani A, Peretti GM, et al. . Long-Term Coronavirus Disease 2019 Complications in Inpatients and Outpatients: A One-Year Follow-up Cohort Study. Open Forum Infect Dis 2021; 8: ofab384. doi:10.1093/ofid/ofab384</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab384</ArticleId><ArticleId IdType="pmc">PMC8344801</ArticleId><ArticleId IdType="pubmed">34386546</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Guida F, Polesel J, et al. . Sequelae in adults at 12&#x2005;months after mild-to-moderate coronavirus disease 2019 (COVID-19). Int Forum Allergy Rhinol 2021; 11: 1685&#x2013;1688. doi:10.1002/alr.22832</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22832</ArticleId><ArticleId IdType="pmc">PMC9291310</ArticleId><ArticleId IdType="pubmed">34109765</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E, van Willigen HDG, Dijkstra M, et al. . Evolution of COVID-19 symptoms during the first 12&#x2005;months after illness onset. Clin Infect Dis 2021; in press [10.1093/cid/ciab759].</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab759</ArticleId><ArticleId IdType="pmc">PMC8522402</ArticleId><ArticleId IdType="pubmed">34473245</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Yu H, Li R, et al. . 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med 2021; 9: 747&#x2013;754. doi:10.1016/S2213-2600(21)00174-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KGI, Brokstad KA, et al. . Long COVID in a prospective cohort of home-isolated patients. Nat Med 2021; 27: 1607&#x2013;1613. doi:10.1038/s41591-021-01433-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Spruit MA, Holland AE, Singh SJ, et al. . COVID-19: Interim Guidance on Rehabilitation in the Hospital and Post-Hospital Phase from a European Respiratory Society and American Thoracic Society-coordinated International Task Force. Eur Respir J 2020; 56: 2002197. doi:10.1183/13993003.02197-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02197-2020</ArticleId><ArticleId IdType="pmc">PMC7427118</ArticleId><ArticleId IdType="pubmed">32817258</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, et al. . Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ 2021; 372: n136. doi:10.1136/bmj.n136</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Akl EA, Blazic I, Yaacoub S, et al. . Use of Chest Imaging in the Diagnosis and Management of COVID-19: A WHO Rapid Advice Guide. Radiology 2021; 298: E63&#x2013;E69. doi:10.1148/radiol.2020203173</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020203173</ArticleId><ArticleId IdType="pmc">PMC7393953</ArticleId><ArticleId IdType="pubmed">32729811</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockwood K, Song X, MacKnight C, et al. . A global clinical measure of fitness and frailty in elderly people. CMAJ 2005; 173: 489&#x2013;495. doi:10.1503/cmaj.050051</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.050051</ArticleId><ArticleId IdType="pmc">PMC1188185</ArticleId><ArticleId IdType="pubmed">16129869</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalmers JD, Crichton ML, Goeminne PC, et al. . Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline. Eur Respir J 2021; 57: 2100048. doi:10.1183/13993003.00048-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00048-2021</ArticleId><ArticleId IdType="pmc">PMC7947358</ArticleId><ArticleId IdType="pubmed">33692120</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhazzani W, M&#xf8;ller MH, Arabi YM, et al. . Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020; 46: 854&#x2013;887. doi:10.1007/s00134-020-06022-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06022-5</ArticleId><ArticleId IdType="pmc">PMC7101866</ArticleId><ArticleId IdType="pubmed">32222812</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham BL, Brusasco V, Burgos F, et al. . ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J 2017; 2017: 1600016. doi:10.1183/13993003.00016-2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00016-2016</ArticleId><ArticleId IdType="pubmed">28049168</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham BL, Steenbruggen I, Barjaktarevic IZ, et al. . Standardization of spirometry 2019 update an official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med 2019; 200: e70&#x2013;e88. doi:10.1164/rccm.201908-1590ST</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201908-1590ST</ArticleId><ArticleId IdType="pmc">PMC6794117</ArticleId><ArticleId IdType="pubmed">31613151</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanger J, Clausen JL, Coates A, et al. . Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: 511&#x2013;522. doi:10.1183/09031936.05.00035005</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.05.00035005</ArticleId><ArticleId IdType="pubmed">16135736</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyns A, Dupont J, Gielen E, et al. . Impact of COVID-19: urging a need for multi-domain assessment of COVID-19 inpatients. Eur Geriatr Med 2021; 12: 741&#x2013;748. doi:10.1007/s41999-021-00486-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41999-021-00486-4</ArticleId><ArticleId IdType="pmc">PMC8009466</ArticleId><ArticleId IdType="pubmed">33786747</ArticleId></ArticleIdList></Reference><Reference><Citation>Nellessen AG, Don&#xe1;ria L, Hernandes NA, et al. . Analysis of three different equations for predicting quadriceps femoris muscle strength in patients with COPD. J Bras Pneumol 2015; 41: 305&#x2013;312. doi:10.1590/S1806-37132015000004515</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1806-37132015000004515</ArticleId><ArticleId IdType="pmc">PMC4635950</ArticleId><ArticleId IdType="pubmed">26398750</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathiowetz V, Weber K, Volland G, et al. . Reliability and validity of grip and pinch strength evaluations. J Hand Surg Am 1984; 9: 222&#x2013;226. doi:10.1016/S0363-5023(84)80146-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0363-5023(84)80146-X</ArticleId><ArticleId IdType="pubmed">6715829</ArticleId></ArticleIdList></Reference><Reference><Citation>Decramer M, Lacquet LM, Fagard R, et al. . Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med 1994; 150: 11&#x2013;16. doi:10.1164/ajrccm.150.1.8025735</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.150.1.8025735</ArticleId><ArticleId IdType="pubmed">8025735</ArticleId></ArticleIdList></Reference><Reference><Citation>Holland AE, Spruit MA, Troosters T, et al. . An official European Respiratory Society/American Thoracic Society technical standard: Field walking tests in chronic respiratory disease. Eur Respir J 2014; 44: 1428&#x2013;1446. doi:10.1183/09031936.00150314</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00150314</ArticleId><ArticleId IdType="pubmed">25359355</ArticleId></ArticleIdList></Reference><Reference><Citation>Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J 1999; 14: 270&#x2013;274. doi:10.1034/j.1399-3003.1999.14b06.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-3003.1999.14b06.x</ArticleId><ArticleId IdType="pubmed">10515400</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan F, Ye T, Sun P, et al. . Time course of lung changes at chest CT during recovery from Coronavirus disease 2019 (COVID-19). Radiology 2020; 295: 715&#x2013;721. doi:10.1148/radiol.2020200370</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020200370</ArticleId><ArticleId IdType="pmc">PMC7233367</ArticleId><ArticleId IdType="pubmed">32053470</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware J, Kosinski M, Keller S. S F-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, MA, Health Assessment Lab, New England Medical Center, 1994.</Citation></Reference><Reference><Citation>Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361&#x2013;370. doi:10.1111/j.1600-0447.1983.tb09716.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Farivar SS, Cunningham WE, Hays RD. Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.1. Health Qual Life Outcomes 2007; 5: 54. doi:10.1186/1477-7525-5-54</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-5-54</ArticleId><ArticleId IdType="pmc">PMC2065865</ArticleId><ArticleId IdType="pubmed">17825096</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall JC, Murthy S, Diaz J, et al. . A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis 2020; 20: e192&#x2013;e197. doi:10.1016/S1473-3099(20)30483-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30483-7</ArticleId><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyrwich K, Yu H, Sato R, et al. . Observational longitudinal study of symptom burden and time for recovery from community-acquired pneumonia reported by older adults surveyed nationwide using the CAP Burden of Illness Questionnaire. Patient Relat Outcome Meas 2015; 6: 215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525785</ArticleId><ArticleId IdType="pubmed">26257528</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui DS, Wong KT, Ko FW, et al. . The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest 2005; 128: 2247&#x2013;2261. doi:10.1378/chest.128.4.2247</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.128.4.2247</ArticleId><ArticleId IdType="pmc">PMC7094276</ArticleId><ArticleId IdType="pubmed">16236881</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397: 220&#x2013;232. doi:10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Faverio P, Luppi F, Rebora P, et al. . Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study. Respiration 2021; 100: 1078&#x2013;1087. doi:10.1159/000518141</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000518141</ArticleId><ArticleId IdType="pmc">PMC8450855</ArticleId><ArticleId IdType="pubmed">34515212</ArticleId></ArticleIdList></Reference><Reference><Citation>Smet J, Stylemans D, Hanon S, et al. . Clinical status and lung function 10&#x2005;weeks after severe SARS-CoV-2 infection. Respir Med 2021; 176: 106276. doi:10.1016/j.rmed.2020.106276</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2020.106276</ArticleId><ArticleId IdType="pmc">PMC7701883</ArticleId><ArticleId IdType="pubmed">33278758</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, et al. . Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 2020; 383: 120&#x2013;128. doi:10.1056/NEJMoa2015432</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Belli S, Balbi B, Prince I, et al. . Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalisation. Eur Respir J 2020; 56: 2002096. doi:10.1183/13993003.02096-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02096-2020</ArticleId><ArticleId IdType="pmc">PMC7411272</ArticleId><ArticleId IdType="pubmed">32764112</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Aerde N, Van den Berghe G, Wilmer A, et al. . Intensive care unit acquired muscle weakness in COVID-19 patients. Intensive Care Med 2020; 46: 2083&#x2013;2085. doi:10.1007/s00134-020-06244-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06244-7</ArticleId><ArticleId IdType="pmc">PMC7520507</ArticleId><ArticleId IdType="pubmed">32986233</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang TJ, Chau B, Lui M, et al. . Physical medicine and rehabilitation and pulmonary rehabilitation for COVID-19. Am J Phys Med Rehabil 2020; 99: 769&#x2013;774. doi:10.1097/PHM.0000000000001505</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001505</ArticleId><ArticleId IdType="pmc">PMC7315835</ArticleId><ArticleId IdType="pubmed">32541352</ArticleId></ArticleIdList></Reference><Reference><Citation>Everaerts S, Heyns A, Langer D, et al. . COVID-19 recovery: benefits of multidisciplinary respiratory rehabilitation. BMJ Open Respir Res 2021; 8: e000837. doi:10.1136/bmjresp-2020-000837</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2020-000837</ArticleId><ArticleId IdType="pmc">PMC8423511</ArticleId><ArticleId IdType="pubmed">34489236</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin L, Savale L, Pham T, et al. . Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA 2021; 325: 1525&#x2013;1534. doi:10.1001/jama.2021.3331</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanpee G, Hermans G, Segers J, et al. . Assessment of limb muscle strength in critically ill patients: a systematic review. Crit Care Med 2014; 42: 701&#x2013;711. doi:10.1097/CCM.0000000000000030</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000030</ArticleId><ArticleId IdType="pubmed">24201180</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>